Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2023/4/5 申報
- 申報編號
- 0001968202-23-000006
- 申報時間
- 2023/4/5
- 交易日
- 2023/4/3
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 8 筆非衍生性交易。公開市場賣出合計 $8.19 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/4/3 | Common Stock | S賣出處分 | −7 | $816.58F2 | −$5,716.06 | 19,140 | 直接 | |
| 2023/4/3 | Common Stock | S賣出處分 | −13 | $817.49F3 | −$10,627.37 | 19,127 | 直接 | |
| 2023/4/3 | Common Stock | S賣出處分 | −27 | $818.47F4 | −$22,098.69 | 19,100 | 直接 | |
| 2023/4/3 | Common Stock | S賣出處分 | −32 | $819.48F5 | −$26,223.36 | 19,068 | 直接 | |
| 2023/4/3 | Common Stock | S賣出處分 | −5 | $820.55F6 | −$4,102.75 | 19,063 | 直接 | |
| 2023/4/3 | Common Stock | S賣出處分 | −1 | $821.61 | −$821.61 | 19,062 | 直接 | |
| 2023/4/3 | Common Stock | S賣出處分 | −9 | $822.37F7 | −$7,401.33 | 19,053 | 直接 | |
| 2023/4/3 | Common Stock | S賣出處分 | −6 | $823.34F8 | −$4,940.04 | 19,047 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 7 shares of Company stock on April 3, 2023 at prices ranging from $816.15 to $816.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 13 shares of Company stock on April 3, 2023 at prices ranging from $817.01 to $817.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 27 shares of Company stock on April 3, 2023 at prices ranging from $818.04 to $818.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 32 shares of Company stock on April 3, 2023 at prices ranging from $819.01 to $819.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 5 shares of Company stock on April 3, 2023 at prices ranging from $820.22 to $820.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 9 shares of Company stock on April 3, 2023 at prices ranging from $822.06 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 6 shares of Company stock on April 3, 2023 at prices ranging from $823.11 to $823.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2023 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。